我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

哺乳动物心脏离子通道的分布、功能及其分子基础的研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第4期
页码:
610-615
栏目:
综述
出版日期:
2010-06-10

文章信息/Info

Title:
-
作者:
张娟; 成建华
同济大学医学院药理学教研室，上海 200092
Author(s):
-
关键词:
钾通道; 钠通道; 钙通道; 氯通道; 心脏
Keywords:
-
分类号:
R966;R321.31
DOI:
-
文献标识码:
A
摘要:
心肌细胞膜上存在多种离子通道，这些通道表达和功能的正常是心脏生物电活动的基础。本文主要总述了心肌细胞常见的钾通道、钠通道、钙通道以及氯通道等在哺乳动物、特别是人类心脏不同部位心肌细胞的分布和其独特的功能结构特点，从而为进一步了解离子通道与人类心脏疾病的关联提供重要的理论基础。
Abstract:
-

参考文献/References

［1］李泱，王士雯． 离子通道学的未来发展及可能遇到的问题［J］. 中国心脏起搏与心电生理杂志, 2006, 20(6): 538-546.

［2］史路平,王军. ATP敏感性钾通道的容积调控特性研究发展［J］. 心脏杂志, 2009, 21（2）:267-270.

［3］Radicke S, Cotella D, Graf EM, et al. Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative β-subunit of human cardiac transient outward current encoded by Kv4.3［J］. J Physiol, 2005, 565(Pt3): 751-756.

［4］Wang YG, Cheng J, Tandan S, et al. Transient-outward K+ channel inhibition facilitates L-type Ca2+ current in heart［J］. J Cardiovasc Electrophysiol, 2006, 17(3): 298-304.

［5］Jost N, Papp JG,Varró A. Slow delayed rectifier potassium current (IKs) and the repolarization reserve［J］. Ann Noninvasive Electrocardiol, 2007, 12(1):64-78.

［6］Hancox JC, McPate MJ, Harchi AE, et al. The hERG potassium channel and hERG screening for drug-induced torsades de pointes［J］. Pharmacol Ther, 2008, 119(2):118-132.

［7］Larsen AP, Olesen SP, Grunnet M, et al. Characterization of hERG1a and hERG1b potassium channels-a possible role for hERG1b in the IKr current［J］. Pflügers Arch-Eur J Physiol, 2008, 456(6):1137-1148.

［8］Manderfield LJ, George AL Jr. KCNE4 can co-associate with the I(Ks) (KCNQ1-KCNE1) channel complex［J］. FEBS J, 2008, 275(6):1336-1349.

［9］Mustapha Z, Pang L, Nattel S. Characterization of the cardiac KCNE1 gene promoter［J］. Cardiovasc Res, 2007, 73(1):82-91.

［10］Zitron E, Günth M, Scherer D, et al. Kir2.x inward rectifier potassium channels are differentially regulated by adrenergic α1A receptors［J］. J Mol Cell Cardiol, 2008, 44(1):84-94.

［11］Ehrlich JR. Inward rectifier potassium currents as a target for atrial fibrillation therapy［J］. J Cardiovasc Pharmacol, 2008, 52(2):129-135.

［12］周逸,唐其柱. ATP敏感性钾通道在缺血预适应中的作用［J］ . 心脏杂志, 2005, 17（1）:83-86.

［13］Zünkler BJ. Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects［J］. Pharmacol Ther, 2006, 112(1):12-37.

［14］Kane GC, Liu XK, Yamada S, et al. Cardiac KATP channels in health and disease［J］. J Mol Cell Cardiol, 2005, 38(6):937-943.

［15］Abriel H, Kass RS. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins［J］. Trends Cardiovasc Med, 2005, 15(1):35-40.

[16]Mohler PJ. Ankyrins and human disease: What the electrophysiologist should know［J］. J Cardiovasc Electrophysiol, 2006, 17(10):1153-1159.

[17]Lowe JS, Palygin O, Bhasin N, et al. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G-dependent cellular pathway［J］. J Cell Biol, 2008, 180(1):173-186.

［18］Fearon IM, Gautier M. From a distinct sodium channel prolonged action potentials in cardiac Purkinje cells： a distinct phenotype arising［J］. Exp Physiol, 2007, 92(1):1-2.

[19]Brette F, Leroy J, Le Guennec JY, et al. Ca2+ currents in cardiac myocytes: Old story， new insights［J］. Prog Biophys Mol Biol, 2006, 91(1-2):1-82.

[20]Findlay I, Suzuki S, Murakami S, et al. Physiological modulation of voltage-dependent inactivation in the cardiac muscle L-type calcium channel: A modelling study［J］. Prog Biophys Mol Biol, 2008, 96(1-3):482-498.

[21]Gregory M, Faber JS, Livshitz L, et al. Kinetic properties of the cardiac L-type Ca2+ channel and Itos role in myocyte electrophysiology: a theoretical investigation［J］. Biophys J, 2007, 92(5):1522-1543.

[22]Bkaily G, Sculptoreanu A, Wang SM, et al. Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells［J］. Peptides, 2005, 26(8):1410-1417.

[23]Li H, Zhang H, Hancox JC, et al. An outwardly rectifying anionic background current in atrial myocytes from the human heart［J］. Biochem Biophys Res Commun, 2007, 359(3):765-770.

[24]Demion M, Guinamard R, El Chemaly A, et al. An outwardly rectifying chloride channel in human atrial cardiomyocytes［J］. Cardiovasc Electrophysiol, 2006, 17(1):60-68.

[25]Verkerk AO, Wilders R, van Borren MM, et al. Pacemaker current (If) in the human sinoatrial node［J］. Eur Heart J, 2007, 28(20):2472-2478.

[26]Barbuti A, Baruscotti M, Difrancesco D. The pacemaker current: from basics to the clinics［J］. Cardiovasc Electrophysiol, 2007, 18(3):342-347.

[27]Cerbai E, Mugelli A. I(f) in non-pacemaker cells: Role and pharmacological implications［J］. Pharmacol Res, 2006, 53(5):416-423.

[28]Chemaly A, Christopne M, Patri S, et al. The heart rate-lowering agent ivabradine inhibits the pacemaker current If in human atrial myocytes［J］. Cardiovasc Electrophysiol, 2007, 18(11):1190-1196.

[29]Azene EM, Xue T, Li RA. Molecular basis of the effect of potassium on heterologously expressed pacemaker (HCN) channels［J］. J Physiol, 2006, 547(Pt2):349-356.

[30]Michels G, Brandt1 MC, Zagidullin N, et al. Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations［J］. Cardiovasc Res, 2008, 78(3):466-475.

[31]Watanabe Y, Koide Y, Kimura J. Topics on the Na+/Ca2+ Exchanger: Pharmacological characterization of Na+/Ca2+ exchanger inhibitors［J］. J Pharmacol Sci, 2006, 102(1):7-16.

[32]Bers DM, Despa S. Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts［J］. J Pharmacol Sci, 2006, 100(5):315-322.

[33]Diedrichs H, Frank K, Schneider CA, et al. Increased functional importance of the Na+-Ca2+ exchanger in contracting failing human myocardium but unchanged activity in isolated vesicles［J］. Int Heart J, 2007, 48(6):755-766.

备注/Memo

备注/Memo:
收稿日期：2009-04-18.通讯作者：成建华，教授，主要从事心血管药理学和心脏电生理 学研究Email:jcheng@tongji.edu.cn 作者简介：张娟，硕士生Email:gongchangruyue@126.com
更新日期/Last Update: 2010-05-20